採用

Associate Director, Corporate Strategy, New Businesses & Integration
Cambridge, MA
·
On-site
·
Full-time
·
1w ago
Compensation
$156,000 - $215,000
Benefits & Perks
•Healthcare
•401(k)
•Equity
•Parental Leave
•Learning Budget
•Gym
•Healthcare
•401k
•Equity
•Parental Leave
•Learning
•Gym
Required Skills
Commercial Due Diligence
Market Research
Financial Forecasting
Competitive Intelligence
Strategic Analysis
Quantitative Analysis
About this Role:
The Corporate Strategy & New Business Integration (CS&NBI) team, part of Biogen’s Corporate Development organization, advises Biogen’s Executive Committee on shaping the company’s long-term strategic direction, evaluating external investment opportunities, and optimizing resources to advance innovative therapies for individuals worldwide facing complex and challenging diseases. In this role, you will lead commercial due diligence on transformational growth opportunities in new therapeutic areas and markets. You will also leverage deep qualitative analysis and quantitative analytics to drive enterprise competitive intelligence and portfolio optimization to support the evolution of the company’s corporate strategic plan.
What You’ll Do:
-
Lead commercial due diligence efforts on new therapeutic areas and markets by conducting market research, building revenue and operating expense forecasts, and developing market models ranging from structured scenario analyses to advanced probabilistic simulations (e.g., Monte Carlo).
-
Drive enterprise-wide competitive intelligence by conducting qualitative assessments of peer companies paired with quantitative benchmarking to generate actionable insights and strategic implications.
-
Support portfolio optimization and capital allocation, including external benchmarking and scenario-based sensitivity analysis.
-
Collaborate with senior leaders across regions and functions to create business cases and investment recommendations.
-
Enhance the capabilities of the CS&NBI team by integrating best practices in analytical methodologies, decision-making frameworks, and cross-functional collaboration.
-
Develop custom analog libraries that integrate internal performance data with external benchmarks to guide opportunities evaluations, scenario planning, and portfolio decision making.
Who You Are:
You are a strategic thinker with a strong foundation in both deep quantitative and qualitative analysis, capable of dissecting complex problems with precision and clarity. You bring attention to detail, intellectual rigor, and the ability to translate insights into clear, actionable recommendations for senior leaders. You excel in fast-paced environments, operate with an entrepreneurial mindset, and influence effectively across functions and seniority levels, all while upholding the highest standards of ethics and integrity.
Required Skills:
-
10+ years of professional experience ideally in Life Sciences, or at least 5 years of relevant experience in commercial, consulting, or strategy roles within the Life Sciences sector is required.
-
Extensive experience leading commercial due diligence efforts with a proven ability to conduct rigorous market research, develop detailed revenue and expense forecasts.
-
Skilled in conducting enterprise-level competitive intelligence through qualitative analysis and quantitative benchmarking to provide actionable insights and strategic recommendations.
-
Proven ability to distill complex analyses into clear, compelling and objective recommendations for senior leadership and board-level audiences.
-
A track record of navigating and influencing across matrixed organizations, driving alignment among senior leaders, and fostering collaboration across regions and functions.
Job Level: Management
Additional Information:
The base compensation range for this role is: $156,000.00-$215,000.00
Base salary offered is determined through an analytical approach utilizing a combination of factors including, but not limited to, relevant skills & experience, job location, and internal equity.
Regular employees are eligible to receive both short term and long-term incentives, including cash bonus and equity incentive opportunities, designed to reward recent achievements and recognize your future potential based on individual, business unit and company performance.
In addition to compensation, Biogen offers a full and highly competitive range of benefits designed to support our employees’ and their families physical, financial, emotional, and social well-being; including, but not limited to:
- Medical, Dental, Vision, & Life insurances
- Fitness & Wellness programs including a fitness reimbursement
- Short- and Long-Term Disability insurance
- A minimum of 15 days of paid vacation and an additional end-of-year shutdown time off (Dec 26-Dec 31)
- Up to 12 company paid holidays + 3 paid days off for Personal Significance
- 80 hours of sick time per calendar year
- Paid Maternity and Parental Leave benefit
- 401(k) program participation with company matched contributions
- Employee stock purchase plan
- Tuition reimbursement of up to $10,000 per calendar year
- Employee Resource Groups participation
Why Biogen?
We are a global team with a commitment to excellence, and a pioneering spirit. As a mid-sized biotechnology company, we provide the stability and resources of a well-established business while fostering an environment where individual contributions make a significant impact. Our team encompasses some of the most talented and passionate achievers who have unparalleled opportunities for learning, growth, and expanding their skills. Above all, we work together to deliver life-changing medicines, with every role playing a vital part in our mission. Caring Deeply. Achieving Excellence. Changing Lives.
At Biogen, we are committed to building on our culture of inclusion and belonging that reflects the communities where we operate and the patients we serve. We know that diverse backgrounds, cultures, and perspectives make us a stronger and more innovative company, and we are focused on building teams where every employee feels empowered and inspired. Read on to learn more about our DE&I efforts.
All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.
Total Views
0
Apply Clicks
0
Mock Applicants
0
Scraps
0
Similar Jobs

Head of Enterprise Compliance
T. Rowe Price · Owings Mills, MD

Account Executive - Mid-Market (Ontario & Quebec ONLY)
HubSpot · Remote - Ontario, Canada

Global Head of Technology Sourcing
Block (Square) · Bay Area, CA, United States of America

Senior Director Paid Performance Channels Mktg
Empower · KS Kansas City - Remote

Director of FP&A – Services
F5 Networks · Seattle
About Biogen

Biogen
PublicSpecializing in the treatment of neurological diseases.
5,001-10,000
Employees
Cambridge
Headquarters
Reviews
4.1
47 reviews
Work Life Balance
3.6
Compensation
4.7
Culture
4.1
Career
4.4
Management
3.8
84%
Recommend to a Friend
Pros
Opportunities for continuous learning and growth
Strong engineering culture with focus on code quality
Cutting-edge technology stack and interesting technical challenges
Cons
Organizational changes and restructuring can be disruptive
Fast-paced environment with tight deadlines
Work-life balance can be challenging during product launches
Salary Ranges
541 data points
Mid/L4
Senior/L5
Mid/L4 · SR Analyst, R&D Business Ops
1 reports
$131,388
total / year
Base
$114,250
Stock
-
Bonus
-
$131,388
$131,388
Interview Experience
47 interviews
Difficulty
3.5
/ 5
Duration
14-28 weeks
Offer Rate
36%
Experience
Positive 65%
Neutral 25%
Negative 10%
Interview Process
1
Phone Screen
2
Technical Interview
3
System Design
4
Behavioral
5
Team Fit
Common Questions
Tell me about a challenging project
System design question
Coding problem
Why this company
News & Buzz
FDA grants breakthrough therapy designation to Biogen’s litifilimab - Investing.com
Source: Investing.com
News
·
5w ago
Biogen’s Litifilimab Receives FDA Breakthrough Therapy Designation for Cutaneous Lupus Erythematosus, a Disease With No Targeted Treatment Options - Biogen
Source: Biogen
News
·
5w ago
FDA Accepts LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease under Priority Review - Biogen
Source: Biogen
News
·
5w ago
Biogen’s Alisha Alaimo On The Company’s Next Big Commercial Build - Citeline News & Insights
Source: Citeline News & Insights
News
·
6w ago